Comparative Effectiveness of Nintedanib and Pirfenidone in Patients Diagnosed With Idiopathic Pulmonary Fibrosis

被引：0

作者：

Shankar, D. ^{[1
]}

Law, A. ^{[1
]}

Walkey, A. J. ^{[1
]}

Hawkins, F. J. ^{[1
]}

Alysandratos, K. ^{[2
]}

Wilson, K. C. ^{[1
]}

Bosch, N. A. ^{[1
]}

机构：

[1] Boston Univ, Sch Med, Boston, MA 02118 USA

[2] Boston Univ, Sch Med, Pulm, Boston, MA 02118 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A2481

引用

页数：2

共 50 条

[41] Recent trends in pirfenidone and nintedanib use for idiopathic pulmonary fibrosis in Australia [J].

Cox, Ingrid A. ;

de Graaff, Barbara ;

Corte, Tamera J. ;

Glaspole, Ian ;

Chambers, Daniel C. ;

Moodley, Yuben ;

Teoh, Alan ;

Walters, E. Haydn ;

Palmer, Andrew J. .

AUSTRALIAN HEALTH REVIEW, 2021, 45 (06) :718-727

[42] Real World Experience of Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis [J].

Mulholland, S. A. ;

Al Jbour, K. ;

Steer, H. ;

Gutsche, M. ;

Foley, N. ;

Srivastava, R. ;

Sharp, C. ;

Adamali, H. I. ;

Barratt, S. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197

[43] Indication for and Impact of Switching from Pirfenidone to Nintedanib in Idiopathic Pulmonary Fibrosis [J].

Hogben, C. ;

Kouranos, V. ;

Kokosi, M. ;

Renzoni, E. A. ;

Chua, F. ;

Wells, A. U. ;

Maher, T. M. ;

Molyneaux, P. L. ;

George, P. M. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197

[44] Evaluation of Idiopathic Pulmonary Fibrosis therapies, Pirfenidone and Nintedanib, in a Human Experimental Model of Fibrosis [J].

Roach, Katy ;

Castells, E. ;

Tongue, P. ;

Elliott, G. ;

Marshall, H. ;

Richardson, M. ;

Chachi, L. ;

Mason, S. ;

Sutcliffe, A. ;

Bradding, P. .

EUROPEAN RESPIRATORY JOURNAL, 2019, 54

[45] Histopathological and molecular analysis of idiopathic pulmonary fibrosis lungs from patients treated with pirfenidone or nintedanib [J].

Zhang, Yingwei ;

Jones, Kirk D. ;

Achtar-Zadeh, Natalia ;

Green, Gary ;

Kukreja, Jasleen ;

Xu, Biyun ;

Wolters, Paul J. .

HISTOPATHOLOGY, 2019, 74 (02) :341-349

[46] Healthcare resource use and related costs in patients receiving nintedanib or pirfenidone for idiopathic pulmonary fibrosis [J].

Bonniaud, Philippe ;

Cottin, Vincent ;

Spagnolo, Paolo ;

Nolin, Maeva ;

Dalon, Faustine ;

Kirchgassler, Klaus-Uwe ;

Chia, Jenny ;

Kamath, Tripthi ;

Van Ganse, Eric ;

Belhassen, Manon .

EUROPEAN RESPIRATORY JOURNAL, 2020, 56

[47] Histopathologic and Molecular Analysis of Idiopathic Pulmonary Fibrosis Lungs from Patients Treated with Pirfenidone or Nintedanib [J].

Zhang, Yingwei ;

Jones, Kirk ;

Achtar-Zadeh, Natalia ;

Kukreja, Jasleen ;

Wolters, Paul .

EUROPEAN RESPIRATORY JOURNAL, 2018, 52

[48] Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis [J].

Cottin, Vincent ;

Spagnolo, Paolo ;

Bonniaud, Philippe ;

Dalond, Faustine ;

Nolind, Maeva ;

Kirchgassler, Klaus-Uwe ;

Van Ganse, Eric ;

Belhassen, Manon .

RESPIRATORY MEDICINE AND RESEARCH, 2023, 83

[49] TREATMENT COST COMPARISON OF PIRFENIDONE VERSUS NINTEDANIB ON THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS [J].

Ho, R. ;

Rufino, C. ;

Lisondo, C. ;

Alves, M. .

VALUE IN HEALTH, 2017, 20 (09) :A893-A893

[50] Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis Results of the INJOURNEY Trial [J].

Vancheri, Carlo ;

Kreuter, Michael ;

Richeldi, Luca ;

Ryerson, Christopher J. ;

Valeyre, Dominique ;

Grutters, Jan C. ;

Wiebe, Sabrina ;

Stansen, Wibke ;

Quaresma, Manuel ;

Stowasser, Susanne ;

Wuyts, Wim A. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (03) :356-363

← 1 2 3 4 5 →